Recent Analysts’ Ratings Changes for Avantor (AVTR)

Several brokerages have updated their recommendations and price targets on shares of Avantor (NYSE: AVTR) in the last few weeks:

• 10/29/2026 – Avantor had its “hold” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $17.00 price target on the stock.
• 10/29/2026 – Avantor had its price target raised by Barclays from $15.00 to $16.00. They now have an “underweight” rating on the stock.
• 10/29/2026 – Avantor had its price target raised by Stifel Nicolaus from $15.00 to $18.00. They now have a “hold” rating on the stock.
• 10/29/2026 – Avantor had its price target raised by Robert W. Baird from $17.00 to $18.00. They now have an “outperform” rating on the stock.
• 10/28/2026 – Avantor was given a new $17.00 price target by Evercore.
• 10/28/2026 – Avantor had its price target raised by Royal Bank Of Canada from $14.00 to $17.00. They now have a “sector perform” rating on the stock.
• 10/13/2026 – Avantor had its price target raised by TD Cowen from $15.00 to $17.00. They now have a “hold” rating on the stock.
• 10/13/2026 – Avantor had its price target raised by Morgan Stanley from $14.00 to $15.00. They now have an “equal weight” rating on the stock.
• 10/11/2026 – Avantor was upgraded by Wall Street Zen from “hold” to “buy”.
• 10/7/2026 – Avantor had its price target raised by Barclays from $13.00 to $15.00. They now have an “underweight” rating on the stock.
• 10/3/2026 – Avantor was downgraded by Wall Street Zen from “buy” to “hold”.
• 9/9/2026 – Avantor is now covered by UBS Group. They set a “neutral” rating and a $16.00 price target on the stock.

Avantor Price Performance

Shares of NYSE AVTR opened at $15.14 on Friday. Avantor, Inc. has a fifty-two week low of $7.26 and a fifty-two week high of $17.45. The business has a 50 day moving average price of $15.58 and a two-hundred day moving average price of $11.31. The company has a quick ratio of 1.27, a current ratio of 1.89 and a debt-to-equity ratio of 0.63. The firm has a market cap of $10.26 billion, a PE ratio of 30.29, a price-to-earnings-growth ratio of 7.08 and a beta of 0.95.

Avantor (NYSE:AVTR) last announced its earnings results on Wednesday, October 28th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. Avantor had a return on equity of 9.79% and a net margin of 5.08%. The company had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period in the prior year, the company posted $0.22 EPS. Avantor’s quarterly revenue was up 4.6% on a year-over-year basis. Sell-side analysts expect that Avantor, Inc. will post 0.82 earnings per share for the current fiscal year.

Avantor, Inc is a global provider of mission-critical products and services used in the life sciences, healthcare, education, and advanced technology industries. The company supplies chemicals, reagents, laboratory consumables, equipment, and other materials used in research, development, manufacturing, and quality-control activities.

Avantor also provides specialized solutions for biopharmaceutical production, including materials and services that support drug development, biologics manufacturing, and other bioprocessing applications.